Synthesis Of Literature: The Immune Enhancers Pidotimod Synthesis – Accelerator Pidotimod, Immune –

By | April 5, 2018

Chemical name (R) -3 – [(S) – (5 – O -2 – pyrrolo alkyl) carbonyl] – thiazolidine -4 – formic acid, is a new synthetic immune enhancers, and its structure similar to the dipeptide. Good oral and intramuscular bioavailability, both for non-specific immune response and contribute to specific immune response [1]; can promote macrophage and neutrophil phagocytic activity, activation of natural killer cells [2] ; promote mitotic cell proliferation caused by the source, so that when the change in immunocompromised T cells and helper T cell suppression ratio returned to normal [3]; by stimulating IL -2 and IFN- promote the cellular immune response [ 4]. Clinical prevention and treatment of children for recurrent respiratory infections (RRI), chronic bronchitis, recurrent urinary tract infection and adjuvant treatment of malignant Cancer Swift progress has been satisfactory results. Its good tolerance, low incidence of adverse reactions. This product is in the late ’80s by the Italian Poli developed chemical industry, and in 1993 the brand name Polimod the first time in Italy is listed as inhibition of tumor cell growth and recurrent episodes of respiratory and urinary tract infection [5].

We refer to [6 ~ 8] and were modified L-cysteine and L-pyroglutamic acid as the starting material, 3-step reaction by successfully synthesized pidotimod samples. The first step reaction L-thiazolidine -4 – carboxylic acid preparation than [6] greatly improved [6] is L-cysteine hydrochloride with formaldehyde, then adding pyridine and ethanol, high cost and serious pollution; and we need only L-cysteine with formaldehyde can, low cost, simple operation and less pollution.

Specific synthesis: 1 L-thiazolidine -4 – carboxylic acid (2)
In 1L beaker, then added to the L-cysteine (60g, 0.38mol), distilled water (240ml) was dissolved by adding 40% formaldehyde solution (34ml, 0.38mol), at room temperature for overnight, Filter Was a colorless needle crystal, crude distilled water (100ml) recrystallization filtration, drying was colorless needle crystal 40g (78%), mp: 196 ~ 197 (decomposition), Rotation: [ ] 20D =- 141 (c2, water) [literature [6] mp: 196 ~ 197 , [ ] 20D =- 141 (water)].

2 L-pyroglutamic acid ester of pentachlorophenol (3)
1L three neck bottle in order to join L-pyroglutamic acid (51.6g, 0.4mol), pentachlorophenol (105.4g, 0.4mol), dimethylformamide (DMF, 500ml), dicyclohexyl carbodiimide (DCC, 82.6g, 0.4mol), at 5 and stirred 16h, 60 under vacuum distillation the reaction solution to dry, soaked with the appropriate amount of ethyl acetate, filtered crude product was 73g (50%), may used directly for next step reaction. mp: 179 ~ 182 [literature [7] mp: 180 ~ 184 ].

3 pidotimod (1) 1L 3 neck in the bottle, then added to the L-thiazolidine -4 – carboxylic acid (40g, 0.3mol), triethylamine (30g, 0.3mol), dimethylformamide (500ml), stirred at room temperature 30min, and then joined the PCP L-pyroglutamic acid ester (113g, 0.3mol), at room temperature 24h, filtered, Filtrate 60 under vacuum distillation to dryness, extracted with 500 ml distilled water, aqueous solution with 37% hydrochloric acid (25ml, 0.3mol) acidification, crystallization standing at 10 8h, then filtration crystal 56g, recrystallized with distilled water was fine 50g (69 %), mp: 192 ~ 194 , [ ] 25D =- 150 (c2, 5N HCl) [literature [8] mp: 192 ~ 194 , [ ] 25D =- 150 (c 2,5 N hydrochloric acid )].

[References] [1] Pharmacol Res, 1990,22 (Suppl 2) :126-129.
[2] Arzneim Forsch / Drug Res ,1994,12:1421-1424.
[3] Arzneim Forsch / Drug Res ,1994,12:1476-1479.
[4] Int J Immunother, 1992,8 (4) :212-216.
[5] Drugs Fut, 1994,19 (12) :1133-1134.
[6] J Am Chem Soc ,1937,59:200-206.
[7] J Med Chem, 1970,13 (5): 843.
[8] US 4,839,387 (1989) :13-17.

[9] Arzneim-Forsch/Drug Res, 1994,44

The e-commerce company in China offers quality products such as Package Tracker , Mini Pet Tracker, and more. For more , please visit Mini Pet Tracker today!

Product Description
Nine out of ten startups fail.

It’s the statistic most frequently ignored by first-time entrepreneurs because they think their idea is better, their target market is bigger, or they’ll just work harder than those that will fail.

But, simply having a better idea, bigger market and working harder isn't enough. What every entrepreneur needs is a fast track to the wisdom and experience gained from building successful companies: the tips, secrets, advice, and even shortcuts that make other companies successful.

In The Startup Playbook, the authors share their years of combined knowledge gleaned from building and leading companies to help you make the right decisions to keep your company growing — and out of the startup graveyard.

Featuring proven and repeatable tactics for refining your idea, team-building, raising money, developing a product or service, and more, this book is the essential guide containing everything you need to know as you take the journey from idea to successful startup.

    Leave a Reply